Innovation-Powered

With our clinical pharmacists at the center of the care model, evidence-based decisions can be made to prioritize the most clinically appropriate, cost-effective medication therapies. To execute this clinically-driven approach, you need a way to identify opportunities for prescription interventions and optimizations, and communicate it effectively to patients’ prescribers.

At EmpiRx Health, our pharmacists use advanced population health technologies built on the John’s Hopkin’s ACG model and risk stratification along with AI-powered tools to analyze member care needs and identify opportunities for therapy optimization. No two patient populations are the same, and each population requires tailored strategies and solutions to best serve a plan sponsor’s specific membership. This strategy, paired with a unique level of pharmacist-physician engagement, allows our clinicians to identify gaps in care, improve outcomes, and lower costs.

EmpiRx Health’s pharmacist-led PBM model ensures that all members receive the most clinically appropriate, cost-effective medications to optimize health outcomes. To ensure the appropriateness of drug therapies and provide a first-rate member experience, EmpiRx Health’s clinical pharmacists conduct extensive medication reviews, involving close collaboration with prescribing physicians. Our Clinical Review Messaging solution assures that your members are kept informed of the progress of their clinical review in real-time.

Members receive notifications addressing each step of their clinical review’s status. The notifications include the initial notification that the claim requires clinical review, which is followed by status updates from an initial message that the clinical review has not yet been initiated to a message once the clinical review is in progress. They then receive final status of the clinical review: Approved, Partial Denial, or Denial.

This solution reduces member confusion, while ensuring their peace of mind through up-to-date information on the progress of their clinical review. In addition, the solution improves member satisfaction by assuring members that they are receiving the most clinically-appropriate medication therapies for their specific needs.